TriOptima Company Profile

Background

TriOptima, founded in 2000 and headquartered in Stockholm, Sweden, is a leading provider of post-trade infrastructure and risk management services for the over-the-counter (OTC) derivatives market. The company's mission is to reduce costs, complexity, and operational risk in the OTC derivatives market. Its core services include triReduce for portfolio compression, which terminates redundant trades, and triResolve for portfolio reconciliation and collateral management. In 2018, TriOptima was acquired by CME Group as part of its acquisition of NEX Group and now operates as a specialized service line within CME's Post-Trade and Optimization division.

Key Strategic Focus

TriOptima's strategic focus centers on providing critical post-trade infrastructure and risk management services to the OTC derivatives market. The company's core objectives include:

Portfolio Compression: Through its triReduce service, TriOptima offers multilateral compression services across asset classes, eliminating counterparty and operational risk and reducing operational and capital costs.

Counterparty Exposure Management: The triResolve platform provides proactive portfolio reconciliation, collateral management, and dispute resolution, enhancing control over OTC derivatives counterparty exposure.

Risk Analytics: TriOptima's triCalculate service delivers centralized, web-based independent trade valuations and XVA risk calculations for OTC derivatives, using transparent, consistent models across a range of asset classes and business units.

Margin Management: The triBalance service offers multilateral rebalancing of counterparty risk exposures, simplifying OTC derivative portfolios and reducing the costs associated with maintaining them.

Financials and Funding

TriOptima is a privately held company and does not publicly disclose detailed financial information. However, estimates suggest that the company has annual revenues of approximately €153.6 million for the fiscal year 2024. The company has not publicly disclosed specific funding rounds or investor details.

Pipeline Development

As a provider of post-trade infrastructure and risk management services, TriOptima's "pipeline" primarily consists of the development and enhancement of its service offerings. The company continues to innovate and expand its services to meet the evolving needs of the OTC derivatives market. For instance, TriOptima's triBalance service offers multilateral rebalancing of counterparty risk exposures, addressing challenges associated with uncleared margin and simplifying OTC derivative portfolios.

Technological Platform and Innovation

TriOptima leverages several proprietary technologies and scientific methodologies to deliver its services:

Proprietary Technologies:

triReduce: A multilateral compression service that reduces notional principal outstanding and line items for bilateral credit, interest rate, and commodity derivatives, as well as for cleared interest rate OTC derivative trades and FX forwards.

triResolve: A network community service that provides counterparty exposure management services, including proactive portfolio reconciliation of OTC derivative portfolios, collateral management, and dispute resolution.

triCalculate: A centralized, web-based independent trade valuation and XVA risk calculation service for OTC derivatives, using transparent, consistent models across a range of asset classes and business units.

triBalance: A service offering multilateral rebalancing of counterparty risk exposures, helping firms manage the challenges of dealing with uncleared margin by simplifying OTC derivative portfolios and reducing associated costs.

Significant Scientific Methods:

Portfolio Compression Algorithms: TriOptima employs advanced algorithms to identify and eliminate redundant trades, thereby reducing notional principal outstanding and line items across various asset classes.

Risk Analytics Models: The company utilizes transparent and consistent models for trade valuations and XVA risk calculations, ensuring accuracy and reliability in assessing counterparty exposures.

Leadership Team

TriOptima's leadership team comprises experienced professionals with diverse backgrounds in financial services and technology:

Per Sjöberg: Co-Chief Executive Officer of TriOptima and CEO of triReduce.

Raf Pritchard: Co-Chief Executive Officer of TriOptima and CEO of triResolve.

Yutaka Imanishi: Chief Executive Officer of TriOptima Asia Pacific.

Martin Sandström: Chief Technology Officer.

Market Insights and Competitor Analysis

The OTC derivatives market is characterized by its complexity and the need for efficient post-trade processing solutions. Regulatory changes and the increasing focus on risk management have heightened the demand for services that can streamline operations and mitigate risks. This environment presents opportunities for companies like TriOptima to offer innovative solutions that address these challenges.

TriOptima operates in a competitive landscape with several key players:

AcadiaSoft: A leading provider of risk and collateral management solutions, focusing on initial margin services for OTC derivatives markets.

CloudMargin: Offers a cloud-native collateral and margin management platform catering to banks, asset managers, and brokers of all sizes.

trioptima